A recent study suggests that patients who discontinue new weight-loss injections like Mounjaro or Wegovy may regain lost weight much more quickly than those who halt conventional lifestyle plans.
Findings released in a major health publication demonstrates that while obese people often shed a large proportion of their total mass while using the jabs, the mass returns at an estimated rate of 0.8 kg per month once they quit.
"Individuals purchasing such drugs need to be cognizant of the risk of rapid rebound weight gain when the therapy is stopped," warns expert Dr. Susan Jebb.
That rate of regain means a return to pre-treatment mass in about a year and a half.
Analyzing Therapies
The study, which looked at dozens of studies involving over 9,000 of patients, contrasted the effects of these new drugs with conventional dieting.
Researchers emphasize that people who shed pounds through dieting usually see a slower creep back—around 100 grams monthly—once they finish.
Explaining the Rapid Rebound
Nutrition scientists suggest the mechanism of the jabs accounts for the accelerated regain.
GLP-1 drugs imitate a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.
"Artificially providing GLP-1 levels far above than the body's typical production may cause the system to generate a reduced amount of its endogenous hormone, and may also reduce responsiveness to its actions," explained Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this GLP-1 'fix' results in appetite is no longer kept in check, making binge eating far more likely."
A Lifelong Issue?
Medical guidelines advise the jabs for people with weight-linked health risks, accompanied by recommended lifestyle changes.
A number of clinicians contend that, given the significant potential of weight regain, the therapy might need to be ongoing.
This opinion is reinforced by drug manufacturers, who state that the results "highlight the chronic character of obesity," akin to managing conditions like high blood pressure.
User Accounts
Individuals who have discontinued the medication describe a sudden resurgence of cravings.
"I experienced a switch activating and you're instantly starving," described one woman.
This difficulty is compounded if individuals have not adopted permanent lifestyle or habit modifications during treatment.
Widespread Adoption
Survey data indicate that millions of people in the UK have used these injections in the past year, with desire remaining high.
- Use is more common among women compared to males.
- The middle-aged demographic shows the greatest level of interest.
- Many obtain the drugs through private prescriptions rather than public health services.
Ultimately, experts emphasize that while these medications are powerful tools for weight loss, they are not a magic fix and long-term success likely depends on integrated behavioural support.
